BTLA and esophageal squamous cell carcinoma: In the male population, results demonstrated that the genotype of AG in BTLA rs3112270 lowered the ESCC risk when using AA genotype as a reference (AG vs AA: adjusted OR = 0.78, 95% CI = 0.61‐0.99, P = .042).